New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 21, 2014
06:02 EDTAFFXAffymetrix receives clearance to market CytoScan Dx Assay
Affymetrix announced that it has received 510k clearance from the FDA to market its CytoScan Dx Assay. This assay is intended for the postnatal detection of DNA copy number variants in patients referred for chromosomal testing. CytoScan Dx Assay is designed to help physicians diagnose children’s developmental and intellectual disabilities more comprehensively by enabling a high-resolution genome-wide analysis of genetic aberrations. High resolution analysis can reveal small aberrations not readily seen using traditional techniques.
News For AFFX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 29, 2015
16:02 EDTAFFXAffymetrix backs FY15 revenue growth in mid-single digits, consensus $361.43M
Raises FY15 adjusted EBITDA to 17%-19% from 16%-18%.
16:01 EDTAFFXAffymetrix reports Q2 adjusted EPS 12c, consensus 7c
Subscribe for More Information
July 20, 2015
06:32 EDTAFFXAffymetrix and Cytox announce strategic partnership
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use